{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T17:47:31Z","timestamp":1773596851941,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.taap.2026.117775","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:21:05Z","timestamp":1771604465000},"page":"117775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cinnamaldehyde inhibits the progression of gastric cancer by regulating glycolysis through PTP1B\/PI3K\/AKT\/mTOR signaling pathway"],"prefix":"10.1016","volume":"510","author":[{"given":"Xuejing","family":"Qiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linsong","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2026.117775_bb0005","first-page":"167","article-title":"Gastric Cancer, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Ajani","year":"2022","journal-title":"JNCCN"},{"key":"10.1016\/j.taap.2026.117775_bb0010","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jamaoncol.2016.5281","article-title":"Targeting the PI3K\/AKT\/mTOR pathway for the treatment of mesenchymal triple-negative breast Cancer: evidence from a phase 1 trial of mTOR inhibition in combination with liposomal doxorubicin and bevacizumab","volume":"3","author":"Basho","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.taap.2026.117775_bb0015","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.taap.2026.117775_bb0020","doi-asserted-by":"crossref","DOI":"10.3892\/or.2024.8808","article-title":"The combination of a PTP1B inhibitor, TNFR2 blocker, and PD-1 antibody suppresses the progression of non-small cell lung cancer tumors by enhancing immunocompetence","volume":"52","author":"Gui","year":"2024","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.taap.2026.117775_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70295","article-title":"PI3K\/AKT\/mTOR Axis in Cancer: from pathogenesis to treatment","volume":"6","author":"Jiang","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.taap.2026.117775_bb0030","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nrd895","article-title":"Protein tyrosine phosphatase 1B inhibitors for diabetes","volume":"1","author":"Johnson","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2026.117775_bb0035","article-title":"Recent advances on the analysis and biological functions of Cinnamaldehyde and its derivatives","volume":"14","author":"Karimirad","year":"2025","journal-title":"Antioxidants (Basel, Switzerland)."},{"key":"10.1016\/j.taap.2026.117775_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-025-07092-8","article-title":"Cinnamaldehyde impacts key cellular signaling pathways for induction of programmed cell death in high-grade and low-grade human glioma cells","volume":"18","author":"Kim","year":"2025","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.taap.2026.117775_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137033","article-title":"Protein Tyrosine Phosphatase 1B (PTP1B): a comprehensive review of its role in pathogenesis of human diseases","volume":"25","author":"Ko\u0142odziej-Sobczak","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2026.117775_bb0050","doi-asserted-by":"crossref","first-page":"745","DOI":"10.21873\/anticanres.13171","article-title":"Curcumin and Cinnamaldehyde as PTP1B inhibitors with antidiabetic and anticancer potential","volume":"39","author":"Kostrzewa","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.taap.2026.117775_bb0055","article-title":"Cancer-associated fibroblasts promote imatinib resistance in gastrointestinal stromal tumors through PGK1-mediated metabolic reprogramming","author":"Li","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2026.117775_bb0060","article-title":"Triterpenes of Prunella vulgaris inhibit triple-negative breast Cancer by regulating PTP1B\/PI3K\/AKT\/mTOR and IL-24\/CXCL12\/CXCR4 pathways","volume":"26","author":"Li","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2026.117775_bb0065","article-title":"A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity","author":"Liang","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.taap.2026.117775_bb0070","first-page":"338","article-title":"CD38 is involved in cell energy metabolism via activating the PI3K\/AKT\/mTOR signaling pathway in cervical cancer cells","volume":"57","author":"Liao","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.taap.2026.117775_bb0075","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1535-7163.MCT-12-0131","article-title":"A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo","volume":"11","author":"Liu","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.taap.2026.117775_bb0080","article-title":"Biological effects of cinnamaldehyde in animal cancer models: a systematic review and meta-analysis","volume":"16","author":"Luo","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2026.117775_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-025-15172-y","article-title":"Cyclin B2 facilitates glycolysis and tumor progression in pancreatic ductal adenocarcinoma by promoting histone lactylation","author":"Ma","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.taap.2026.117775_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098191","article-title":"Cinnamaldehyde-rich cinnamon extract induces cell death in Colon Cancer cell lines HCT 116 and HT-29","volume":"24","author":"Nile","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2026.117775_bb0095","article-title":"Eriodictyol suppresses gastric Cancer cells via inhibition of PI3K\/AKT pathway","volume":"15","author":"Shan","year":"2022","journal-title":"Pharm. (Basel, Switzerland)."},{"key":"10.1016\/j.taap.2026.117775_bb0100","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41392-025-02451-0","article-title":"Alpha-enolase influences ATP pool of cytoplasm and lactate homeostasis by regulating glycolysis in gastric cancer","volume":"10","author":"Shu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.taap.2026.117775_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108296","article-title":"Discovery of novel oleanolic acid glycoside derivatives targeting PTP1B\/PI3K\/AKT signaling pathway for the treatment of breast cancer","volume":"157","author":"Song","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.taap.2026.117775_bb0110","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41419-018-0611-0","article-title":"miR-338-3p functions as a tumor suppressor in gastric cancer by targeting PTP1B","volume":"9","author":"Sun","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2026.117775_bb0115","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1080\/15384101.2014.998047","article-title":"Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients","volume":"14","author":"Wang","year":"2015","journal-title":"Cell cycle (Georgetown, Tex.)"},{"key":"10.1016\/j.taap.2026.117775_bb0120","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","article-title":"METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.taap.2026.117775_bb0125","article-title":"Cinnamaldehyde suppressed EGF-induced EMT process and inhibits ovarian Cancer progression through PI3K\/AKT pathway","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2026.117775_bb0130","first-page":"1429","article-title":"MAOA suppresses the growth of gastric cancer by interacting with NDRG1 and regulating the Warburg effect through the PI3K\/AKT\/mTOR pathway","volume":"46","author":"Wang","year":"2023","journal-title":"Cell. Oncol. (Dordrecht, Netherlands)."},{"key":"10.1016\/j.taap.2026.117775_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1570532","article-title":"Frontiers and hot topics in tumor metabolic reprogramming: a bibliometric analysis from 2014 to 2023","volume":"15","author":"Wen","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.taap.2026.117775_bb0140","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10585-022-10168-5","article-title":"PLXDC2 enhances invadopodium formation to promote invasion and metastasis of gastric cancer cells via interacting with PTP1B","volume":"39","author":"Wu","year":"2022","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.taap.2026.117775_bb0145","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10620-019-05771-8","article-title":"miR-146b regulates cell proliferation and apoptosis in gastric Cancer by targeting PTP1B","volume":"65","author":"Xu","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.taap.2026.117775_bb0150","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.3748\/wjg.v29.i16.2452","article-title":"Updates on global epidemiology, risk and prognostic factors of gastric cancer","volume":"29","author":"Yang","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.taap.2026.117775_bb0155","article-title":"Cinnamaldehyde suppresses ovarian cancer progression by activating ROS-mediated apoptosis and mitophagy","volume":"244","author":"Yi","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2026.117775_bb0160","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2022.12638","article-title":"Ophiopogonin-B targets PTP1B to inhibit the malignant progression of hepatocellular carcinoma by regulating the PI3K\/AKT and AMPK signaling pathways","volume":"25","author":"Yuan","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.taap.2026.117775_bb0165","doi-asserted-by":"crossref","first-page":"322","DOI":"10.52586\/4946","article-title":"PLOD1 promotes cell growth and aerobic glycolysis by regulating the SOX9\/PI3K\/Akt\/mTOR signaling pathway in gastric cancer","volume":"26","author":"Zhang","year":"2021","journal-title":"Front. Biosci. (Landmark Ed)."},{"key":"10.1016\/j.taap.2026.117775_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70554","article-title":"Exosomal miR-3126-5p derived from cancer-associated fibroblasts facilitates glycolysis to accelerate NSCLC progression by targeting KLF13 to activate the SH2B1\/IRS1 axis","volume":"15","author":"Zhang","year":"2025","journal-title":"Clin. Transl. Med."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26000712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26000712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T16:50:03Z","timestamp":1773593403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X26000712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":34,"alternative-id":["S0041008X26000712"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.117775","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cinnamaldehyde inhibits the progression of gastric cancer by regulating glycolysis through PTP1B\/PI3K\/AKT\/mTOR signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.117775","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117775"}}